Hongyi Tan

1.6k total citations
51 papers, 1.2k citations indexed

About

Hongyi Tan is a scholar working on Immunology, Pharmacology and Oncology. According to data from OpenAlex, Hongyi Tan has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Pharmacology and 10 papers in Oncology. Recurrent topics in Hongyi Tan's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Immune Response and Inflammation (7 papers). Hongyi Tan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Immune Response and Inflammation (7 papers). Hongyi Tan collaborates with scholars based in China, United States and Malaysia. Hongyi Tan's co-authors include Xiaoli Su, Lemeng Zhang, Pinhua Pan, Dongdong Wu, Haitao Li, Yi Li, Shuai Liu, Minhui Dai, Yongbin Hu and Chengping Hu and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Hongyi Tan

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyi Tan China 16 460 459 279 155 110 51 1.2k
Chun-Ling Liang China 21 530 1.2× 410 0.9× 148 0.5× 200 1.3× 88 0.8× 43 1.6k
Liucheng Li China 18 405 0.9× 230 0.5× 429 1.5× 103 0.7× 102 0.9× 49 1.2k
Guangju Zhao China 22 608 1.3× 336 0.7× 124 0.4× 270 1.7× 248 2.3× 83 1.4k
Shenghao Tu China 20 514 1.1× 270 0.6× 168 0.6× 192 1.2× 82 0.7× 70 1.7k
Sanjeev Noel United States 23 556 1.2× 427 0.9× 78 0.3× 112 0.7× 139 1.3× 48 1.5k
Shihui Lin China 19 247 0.5× 431 0.9× 183 0.7× 225 1.5× 46 0.4× 37 932
Chaoyang Tong China 19 262 0.6× 234 0.5× 190 0.7× 220 1.4× 87 0.8× 58 972
Ben Liu China 14 317 0.7× 321 0.7× 135 0.5× 97 0.6× 63 0.6× 25 887
Shuyun Wang China 19 398 0.9× 246 0.5× 148 0.5× 297 1.9× 130 1.2× 109 1.3k

Countries citing papers authored by Hongyi Tan

Since Specialization
Citations

This map shows the geographic impact of Hongyi Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyi Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyi Tan more than expected).

Fields of papers citing papers by Hongyi Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyi Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyi Tan. The network helps show where Hongyi Tan may publish in the future.

Co-authorship network of co-authors of Hongyi Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyi Tan. A scholar is included among the top collaborators of Hongyi Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyi Tan. Hongyi Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Haigang, Hongyi Tan, Yejun Li, et al.. (2023). Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats. Frontiers in Pharmacology. 13. 49 indexed citations
3.
Tan, Hongyi, et al.. (2023). Acinetobacter baumannii outer membrane protein A induces autophagy in bone marrow‐derived dendritic cells involving the PI3K/mTOR pathway. Immunity Inflammation and Disease. 11(4). e830–e830. 6 indexed citations
4.
Pei, Qi, Bo Yang, Hongyi Tan, et al.. (2022). Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease. Drug Design Development and Therapy. Volume 16. 2261–2274. 1 indexed citations
5.
Li, Yaqian, Junjie Ding, Hongyi Tan, et al.. (2021). External evaluation of published population pharmacokinetic models of polymyxin B. European Journal of Clinical Pharmacology. 77(12). 1909–1917. 12 indexed citations
6.
Li, Yaqian, Jie Huang, Yan Wang, et al.. (2020). Dose investigation of imrecoxib in patients with renal insufficiency based on modelling and simulation. European Journal of Pharmaceutical Sciences. 152. 105449–105449. 4 indexed citations
7.
Dai, Minhui, Hongyi Tan, Jing Deng, et al.. (2020). Cross-infection of adenovirus among medical staff: A warning from the intensive care unit in a tertiary care teaching hospital in China. International Journal of Infectious Diseases. 98. 390–397. 6 indexed citations
8.
Liang, Weijun, et al.. (2019). Long non‐coding RNA MALAT1 sponges miR‐149 to promote inflammatory responses of LPS‐induced acute lung injury by targeting MyD88. Cell Biology International. 44(1). 317–326. 40 indexed citations
9.
Pei, Qi, Jie Huang, Wen-Yu Liu, et al.. (2019). Pharmacokinetic study of imrecoxib in patients with renal insufficiency. European Journal of Clinical Pharmacology. 75(10). 1355–1360. 8 indexed citations
10.
Song, Chao, Haitao Li, Yi Li, et al.. (2019). NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization. Experimental Cell Research. 382(2). 111486–111486. 157 indexed citations
11.
Li, Yi, Haitao Li, Shuai Liu, et al.. (2018). Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Molecular Immunology. 99. 134–144. 131 indexed citations
12.
Deng, Songyun, Lemeng Zhang, Yuhang Ai, et al.. (2017). Role of interferon regulatory factor-1 in lipopolysaccharide-induced mitochondrial damage and oxidative stress responses in macrophages. International Journal of Molecular Medicine. 40(4). 1261–1269. 36 indexed citations
13.
Pei, Qi, Jie Huang, Jingkai Gu, et al.. (2016). Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis. Acta Pharmacologica Sinica. 37(11). 1499–1508. 9 indexed citations
14.
Wu, Dongdong, Pinhua Pan, Xiaoli Su, et al.. (2016). Interferon Regulatory Factor-1 Mediates Alveolar Macrophage Pyroptosis During LPS-Induced Acute Lung Injury in Mice. Shock. 46(3). 329–338. 67 indexed citations
15.
Tang, Fang, Rui Zhou, Zeneng Cheng, et al.. (2015). Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects. Acta Pharmaceutica Sinica B. 6(1). 71–78. 6 indexed citations
16.
Guo, Chengxian, et al.. (2015). DNA Repair Gene Polymorphisms Do Not Predict Response to Radiotherapy-Based Multimodality Treatment of Patients with Rectal Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 16(2). 713–718. 6 indexed citations
17.
Wang, Zhan, et al.. (2014). Lung dendritic cells undergo maturation and polarization towards a T helper type 2-stimulating phenotype in a mouse model of asthma: Role of nerve growth factor. Experimental and Therapeutic Medicine. 8(5). 1402–1408. 9 indexed citations
18.
Pei, Qi, Jinfu Peng, Hongyi Tan, et al.. (2014). Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects. European Journal of Drug Metabolism and Pharmacokinetics. 40(4). 427–433. 3 indexed citations
19.
Guo, Chengxian, Qi Pei, Hongyi Tan, et al.. (2014). Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients. Biomedical Reports. 3(2). 195–200. 18 indexed citations
20.
Yang, Guoping, Xiaoping Chen, Hong Yuan, et al.. (2011). Effects of the CYP Oxidoreductase Ala503Val Polymorphism on CYP3A Activity In Vivo: A Randomized, Open-Label, Crossover Study in Healthy Chinese Men. Clinical Therapeutics. 33(12). 2060–2070. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun-Ling Liang Breakdown of academic impact, for papers by Liucheng Li Breakdown of academic impact, for papers by Guangju Zhao Breakdown of academic impact, for papers by Shenghao Tu Breakdown of academic impact, for papers by Sanjeev Noel Breakdown of academic impact, for papers by Shihui Lin Breakdown of academic impact, for papers by Chaoyang Tong Breakdown of academic impact, for papers by Ben Liu Breakdown of academic impact, for papers by Shuyun Wang
Rankless by CCL
2026